TY - JOUR
T1 - Targeted degradation of proteins by small molecules
T2 - A novel tool for functional proteomics
AU - Zhang, D.
AU - Baek, S. H.
AU - Ho, A.
AU - Lee, H.
AU - Jeong, Y. S.
AU - Kim, K.
PY - 2004/11
Y1 - 2004/11
N2 - A novel strategy that targets protein for degradation has recently been developed by exploiting a p rotein-targeting chimeric molecule ('Protac'). Typically, the chimeric Protac is composed of a small-molecule ligand ('bait') on one end and a synthetic octapeptide on the other. This octapeptide is recognized by E3 ubiquitin ligase pVHL (von Hippel Lindau tumor suppressor protein), thereby recruiting a small molecule-bound protein ('prey') to pVHL for ubiquitination and degradation. Since selective degradation of a cellular protein generates a "loss of function" mutation, this protein knock-out strategy may be useful to study the function of a given protein or to evaluate whether a cellular protein is a potential target for drug intervention, in a manner reminiscent of gene knock-out or siRNA approaches. Herein, we show that a synthetic pentapeptide is sufficient to interact with pVHL E3 ligase, and that the pentapeptide-based Protac efficiently induces ubiquitination and degradation of target protein. Our results also demonstrate that the pentapeptide-based Protac can enter cells efficiently to exerts its biological activity effectively. These results suggest that the synthetic pentapeptide can be used either directly in the preparation of cell-permeable Protacs or as a template to develop peptidomimetic or non-peptide Protacs.
AB - A novel strategy that targets protein for degradation has recently been developed by exploiting a p rotein-targeting chimeric molecule ('Protac'). Typically, the chimeric Protac is composed of a small-molecule ligand ('bait') on one end and a synthetic octapeptide on the other. This octapeptide is recognized by E3 ubiquitin ligase pVHL (von Hippel Lindau tumor suppressor protein), thereby recruiting a small molecule-bound protein ('prey') to pVHL for ubiquitination and degradation. Since selective degradation of a cellular protein generates a "loss of function" mutation, this protein knock-out strategy may be useful to study the function of a given protein or to evaluate whether a cellular protein is a potential target for drug intervention, in a manner reminiscent of gene knock-out or siRNA approaches. Herein, we show that a synthetic pentapeptide is sufficient to interact with pVHL E3 ligase, and that the pentapeptide-based Protac efficiently induces ubiquitination and degradation of target protein. Our results also demonstrate that the pentapeptide-based Protac can enter cells efficiently to exerts its biological activity effectively. These results suggest that the synthetic pentapeptide can be used either directly in the preparation of cell-permeable Protacs or as a template to develop peptidomimetic or non-peptide Protacs.
KW - E3 ubiquitin ligase
KW - Estradiol (E2)
KW - Estrogen receptor (ER)
KW - Hypoxia-inducing factor-1α (HIF-1α)
KW - Post-genomic era
KW - Proteasome
KW - Protein-targeting chimeric molecule (Protac)
KW - Ubiquitin
KW - Von Hippel Lindau tumor suppressor protein (pVHL)
UR - https://www.scopus.com/pages/publications/5644279180
UR - https://www.scopus.com/pages/publications/5644279180#tab=citedBy
U2 - 10.2174/1386207043328364
DO - 10.2174/1386207043328364
M3 - Article
C2 - 15578931
AN - SCOPUS:5644279180
SN - 1386-2073
VL - 7
SP - 689
EP - 697
JO - Combinatorial Chemistry and High Throughput Screening
JF - Combinatorial Chemistry and High Throughput Screening
IS - 7
ER -